Janus Henderson Group PLC Purchases 49,200 Shares of NCR Atleos Corporation $NATL

Janus Henderson Group PLC grew its holdings in shares of NCR Atleos Corporation (NYSE:NATL) by 152.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 81,485 shares of the company’s stock after acquiring an additional 49,200 shares during the period. Janus Henderson Group PLC owned 0.11% of NCR Atleos worth $3,551,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. CIBC Private Wealth Group LLC boosted its position in shares of NCR Atleos by 66.7% during the 4th quarter. CIBC Private Wealth Group LLC now owns 690 shares of the company’s stock valued at $26,000 after purchasing an additional 276 shares in the last quarter. Sound Income Strategies LLC increased its holdings in NCR Atleos by 245.7% in the first quarter. Sound Income Strategies LLC now owns 643 shares of the company’s stock worth $28,000 after purchasing an additional 457 shares in the last quarter. Eurizon Capital SGR S.p.A. acquired a new position in NCR Atleos in the fourth quarter valued at approximately $31,000. Global Retirement Partners LLC lifted its stake in NCR Atleos by 134.5% in the fourth quarter. Global Retirement Partners LLC now owns 1,210 shares of the company’s stock valued at $46,000 after buying an additional 694 shares during the period. Finally, Kestra Advisory Services LLC bought a new position in shares of NCR Atleos during the 4th quarter worth approximately $51,000. 88.66% of the stock is owned by institutional investors.

NCR Atleos Trading Up 0.2%

NYSE:NATL opened at $46.61 on Friday. The company has a debt-to-equity ratio of 5.84, a current ratio of 1.03 and a quick ratio of 0.78. The firm has a 50-day moving average of $45.24 and a 200-day moving average of $43.78. The company has a market cap of $3.44 billion, a PE ratio of 18.07 and a beta of 0.57. NCR Atleos Corporation has a one year low of $33.31 and a one year high of $48.50.

NCR Atleos (NYSE:NATL) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.24). The business had revenue of $1.04 billion during the quarter. NCR Atleos had a net margin of 4.44% and a return on equity of 83.41%. The business’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.64 earnings per share. As a group, equities research analysts expect that NCR Atleos Corporation will post 4.52 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on NATL. Weiss Ratings reiterated a “hold (c+)” rating on shares of NCR Atleos in a research note on Wednesday. Zacks Research cut shares of NCR Atleos from a “strong-buy” rating to a “hold” rating in a report on Wednesday, May 27th. Finally, DA Davidson reaffirmed a “neutral” rating and issued a $50.00 price target on shares of NCR Atleos in a research note on Monday, May 11th. Five analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $50.27.

NCR Atleos Profile

NCR Atleos Corporation operates as a financial technology company in the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Self-Service Banking, Network, and Telecommunications & Technology (T&T). The Self-Service Banking segment offers solutions, including a line of automated teller machine (ATM) and interactive teller machine (ITM) hardware and software, as well as related installation, maintenance, and managed and professional services; and solutions to manage and run the ATM channel end-to-end for financial institutions comprising back office, cash management, software management and ATM deployment, and others.